Outcomes and Safety of Percutaneous Aortic Valve Replacement

Journal of the American College of Cardiology

Volumn 53, Issue 20, 2009, Pages 1829-1836

  Zajarias, Alan ^a   Cribier, Alain G ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

aortic stenosis; catheter; stent; survival; valvuloplasty

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; BLOOD VESSEL INJURY; CATHETER; CLINICAL FEATURE; DISEASE SEVERITY; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PERCUTANEOUS AORTIC VALVE REPLACEMENT; PRIORITY JOURNAL; PROSTHESIS; PROSTHETIC VALVE DYSFUNCTION; RESTENOSIS; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; VASCULAR ACCESS;

AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 65149095001     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.059     Document Type: Review

References (35)

1. Ross Jr. J., and Braunwald E. Aortic stenosis. Circulation 38 Suppl 1 (1968) 61-67
2. Varadarajan P., Kapoor N., Bansal R.C., and Pai R.G. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 82 (2006) 2111-2115
3. Edwards F.H., Peterson E.D., Coombs L.P., et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37 (2001) 885-892
4. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003) 1231-1243
5. Pinna-Pintor P., Bobbio M., Colangelo S., et al. Inaccuracy of four coronary risk adjusted models to predict mortality in individual patients. Eur J Cardiothorac Surg 21 (2002) 199-204
6. Collart F., Feier H., Kerbaul F., et al. Valvular surgery in octogenarians: operative risk factors, evaluation of Euroscore and long term results. Eur J Cardiothorac Surg 27 (2005) 276-280
7. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic Euroscore. Eur Heart J 24 (2003) 882-883
8. Gossi E.A., Schwartz C.F., Yu P.J., et al. High risk aortic valve replacement: are the outcomes as bad as predicted. Ann Thorac Surg 85 (2008) 102-107
9. Shroyer A.L., Coombs L.P., Peterson E., et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75 (2003) 1856-1865
10. Dewey T.M., Brown D., Ryan W., et al. Reliability of risk algorithms in predicting early and late operative outcomes in high risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135 (2008) 180-187
11. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002) 3006-3008
12. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-3
13. Cribier A., Eltchaninoff H., Tron C., et al. Treatment of calcific aortic stenosis with percutaneous heart valve. J Am Coll Cardiol 47 (2006) 1214-1223
14. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (2006) 842-850
15. Webb J.G., Pasupati S., Humphries K., et al. Percutaneous aortic valve replacement in selected high risk patients with aortic stenosis. Circulation 116 (2007) 755-763
16. Lefevre T. The SOURCE Registry. Paper presented at: Transcatheter Cardiovascular Therapeutics, October 13, 2008; Washington, DC.
17. Ye J., Cheung A., Lichtenstein S.V., et al. Six month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 31 (2007) 16-21
18. Lichtenstein S.V., Cheung A., Ye J., et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114 (2006) 591-596
19. Dewey T.M., Walther T., Doss M., et al. Transapical aortic valve implantation: an animal feasibility study. Ann Thorac Surg 82 (2006) 110-116
20. Walther T., Simon P., Dewey T., et al. Transapical minimally invasive aortic valve implantation. Multicenter experience. Circulation 116 Suppl I (2007) I240-I245
21. Svensson L.G., Dewey T., Kapadia S., et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86 (2008) 46-55
22. Walther T. Transapical aortic valve implantation: Traverce Feasibility Study. Paper presented at: Transcatheter Cardiovascular Therapeutics; October 13, 2008; Washington, DC.
23. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the CoreValve self expanding valve prosthesis in high risk patients with aortic valve disease. Circulation 114 (2006) 1616-1624
24. Grube E., Schuler G., Buellesfeld L., et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second and current third generation self expanding CoreValve prosthesis. J Am Coll Cardiol 50 (2007) 69-76
25. Grube E., Gerckens U., Wenaweser P., and Buellesfeld L. Percutaneous aortic valve replacement with CoreValve prosthesis (reply). J Am Coll Cardiol 51 (2008) 170-171
26. Piazza N., Grube E., Gerckens U., et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval). Eurointervention 4 (2008) 242-249
27. Laborde JC. Transcatheter aortic valve implantation with the CoreValve ReValving Device. Paper presented at: Transcatheter Cardiovascular Therapeutics; October 12, 2008; Washington, DC.
28. Buellesfeld L., Gerckens U., and Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 71 (2008) 579-584
29. Low R., Bolling S., Yeo K.K., and Ebner A. Direct Flow Medical percutaneous aortic valve: proof of concept. Eurointervention 4 (2008) 256-261
30. Zegdi R., Ciobotaru V., Noghin M., et al. Is it reasonable to treat all calcified aortic valves with a valved stent?. Results from a human anatomical study in adults. J Am Coll Cardiol 51 (2008) 579-584
31. Cribier A., Savin T., Saoudi N., et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?. Lancet 1 (1986) 63-67
32. Eltchaninoff H., Cribier A., Tron C., et al. Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. Eur Heart J 16 (1995) 1079-1084
33. NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty: acute and 30-day follow up results from the NHLBI Balloon Valvuloplasty Registry. Circulation 84 (1991) 2383-2397
34. Agatiello C., Eltchaninoff H., Tron C., et al. Balloon aortic valvuloplasty in the adult. Immediate results and in-hospital complications in the latest series of 141 consecutive patients at the University Hospital of Rouen (2002-2005). Arch Mal Coeur Vaiss 99 (2006) 195-200
35. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 48 (2006) e1-e148